Overview
Bristol Medical School is set to become the first UK medical school to offer a dedicated teaching placement in cannabis medicine, representing a landmark step in integrating cannabinoid therapeutics into mainstream medical education. This development addresses a critical gap in physician training, as most medical schools currently provide little to no formal instruction on the endocannabinoid system or evidence-based cannabis prescribing. The placement signals growing institutional recognition that cannabis medicine requires the same rigorous clinical training framework as any other therapeutic discipline.
Clinical Perspective
Bristol Medical School just made history by becoming the first UK institution to offer a formal teaching placement in cannabis medicine — and honestly, it’s long overdue. As someone who has treated over 30,000 patients with cannabinoid therapeutics at CED Clinic, I can tell you the single biggest barrier to better patient care is the education gap among physicians.
💊 Most doctors graduate without a single lecture on the endocannabinoid system — one of the largest receptor networks in human physiology
🧠 Formal placements mean students will learn cannabis medicine with the same clinical rigor as cardiology or neurology
⚠️ Better-trained physicians lead directly to safer, more effective patient outcomes
🔹 This sets a precedent that other medical schools across the UK and globally should follow immediately
The medicine is already here. The patients are already here. Now the education is finally catching up.
Have thoughts on this? Share it: